Journal article icon

Journal article

Issues surrounding the health economic evaluation of genomic technologies.

Abstract:

AIM: Genomic interventions could enable improved disease stratification and individually tailored therapies. However, they have had a limited impact on clinical practice to date due to a lack of evidence, particularly economic evidence. This is partly because health economists are yet to reach consensus on whether existing methods are sufficient to evaluate genomic technologies. As different approaches may produce conflicting adoption decisions, clarification is urgently required. This articl...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2217/pgs.13.183

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Population Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
Journal:
Pharmacogenomics
Volume:
14
Issue:
15
Pages:
1833-1847
Publication date:
2013-11-01
DOI:
EISSN:
1744-8042
ISSN:
1462-2416
Source identifiers:
439182
Language:
English
Keywords:
Pubs id:
pubs:439182
UUID:
uuid:a9729b96-b522-4dfe-bb2a-82c7b2c09bce
Local pid:
pubs:439182
Deposit date:
2013-12-13

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP